Founder and CEO of 54gene, Dr. Abasi Ene-Obong, Selected as Endeavor Entrepreneur
Endeavor has welcomed a new entrepreneur into its global network; Dr. Abasi Ene-Obong of 54gene, was selected as an Endeavor Entrepreneur on September 17, 2020. 54gene is a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics and clinical programs. 54gene joins 10 other Endeavor Entrepreneur-led companies in Nigeria, and over 1,300 in Endeavor’s 37 markets across Africa, Latin America, Asia, Europe and North America.
Endeavor is a mission-driven organisation that is leading the global movement for high-impact entrepreneurs and their companies. Endeavor Nigeria selects, mentors and accelerates the best high-impact entrepreneurs in the region, supporting them to scale their companies and drive economic growth. As well as 54gene, this year, Endeavor has welcomed the founders of Daystar Power, Migo and Kobo360 into its local and global network.
Africa is home to the most genetically diverse population in the world. However, less than 3% of the continent’s genomic data is available for research purposes making it a potentially rich source of new genetic information used for medical discoveries. 54gene is solving this challenge and equalising the access to precision medicine through the advancement of the state of healthcare in Nigeria and on the continent. This is being achieved through local clinical research programs and advanced molecular diagnostics.
“54gene is a critical part of the continent’s push to equalize access to precision medicine for millions of Africans. The rapid pace at which the company has scaled over the past year is testament to Dr. Abasi Ene-Obong’s leadership, his drive and talented team. He is an inspiration to other high-impact entrepreneurs in Nigeria and we are thrilled to welcome him into the Endeavor network.” Says Eloho Omame, Managing Director & CEO of Endeavor in Nigeria.
Since launching in 2019, 54gene has scaled its operations in generating novel insights in human genetics research that will lead to high impact health discoveries. At the onset of the COVID-19 pandemic in Nigeria, 54gene raised funds to increase the country’s testing capacity and launched mobile laboratories across 5 Nigerian states. The company has raised $21 million in investment and also launched the African Centre for Translational Genomics (ACTG) to fund the study of Non-Communicable Diseases in 100,000 Nigerians. In September of this year, the company announced a partnership with Illumina to establish a world class genomics facility in Lagos, Nigeria, which will help expand its sequencing-based research and molecular diagnostics offering.
Dr. Abasi Ene-Obong, CEO and Founder of 54gene, says, “It is an absolute honour to be selected as an Endeavor entrepreneur. We started 54gene to significantly improve the inclusion of African populations in global genomics research and I am glad to see our work is being recognised. Our mission is to continue driving innovation and change in research and I look forward to the opportunities that arise as a result of being supported by the global Endeavor network in expanding 54gene’s impact globally.”
Dr. Abasi Ene-Obong was successfully selected as part of a cohort of 9 entrepreneurs from 6 markets. With the recent addition of 54gene, Endeavor Nigeria now supports 17 entrepreneurs who lead 11 scale-up stage companies in Nigeria, spanning lifesciences, fintech, renewable energy, entertainment, logistics and retail.
-ENDS-
For additional information or interview requests with Endeavor Nigeria’s Managing Director and CEO Eloho Omame please contact Ernestina Berry | [email protected] or Oyinloluwa Aboaba | [email protected] of Wimbart
About Endeavor
Established in 1997, Endeavor is a mission-driven, global organization leading the high-impact entrepreneurship movement. Endeavor was founded on the belief that job creation, innovation, and overall prosperity flourish where there is robust support for high-impact entrepreneurs. To date, Endeavor has screened more than 60,000 entrepreneurs and selected more than 2,000 founders leading over 1,200 scale-up companies. Endeavor Entrepreneurs have created over 4 million jobs, generate more than $20 billion in revenue each year, and inspire future generations to innovate, take risks, and build strong entrepreneurship ecosystems in underserved markets. Headquartered in New York City, Endeavor currently operates in nearly 40 growth markets throughout Africa, Asia, Europe, Latin America, the Middle East, and North America.
Endeavor launched its Nigeria office in 2018, to select and support the best founders of companies at
the scaleup stage, who have potential to leverage Endeavor’s global resources, mentors and network to create large-scale wealth and jobs. Endeavor Entrepreneurs are committed to multiplying their impact by reinvesting their time and money to help others in Nigeria’s ecosystem take off. Today, in Nigeria, Endeavor supports 17 Endeavor Entrepreneurs leading 11companies.
About 54gene
54gene is a health technology company advancing the state of healthcare through large-scale discovery and translational research, advanced molecular diagnostics, and inclusive clinical programs for the benefit of Africans and the global population. Founded in 2019, 54gene utilizes human genetic data derived from diverse African populations, to improve the development, availability, and efficacy of medical products and diagnostics that will prove beneficial to Africans and the wider global population.
About the Founder and CEO
Dr. Abasi Ene-Obong holds a PhD in Cancer Biology from University of London, a Masters in human molecular genetics from Imperial College London and a Masters in Business Management from Claremont Colleges, California. He also worked as a cancer researcher and published a seminal paper on pancreatic cancer immunology, Gastroenterology Journal.
He has extensive experience operating in the US, UK and Nigerian healthcare industries. Prior to 54gene, Dr Ene-Obong worked with leading healthcare organisations, including Fortune 100 pharmaceutical companies, academic and research institutions, and governments as a management consultant with PwC and IQVIA (formerly QuintilesIMS). Dr Ene-Obong was also listed as 1 of 30 most innovative entrepreneurs on the African continent in 2019 by Quartz Africa and recently as one of Fortune’s 40 Under 40 in the healthcare category
